Abstract
Composite tissue transplantation is an emerging new era in transplant medicine and has become a viable reconstructive option for patients with large and devastating tissue defects. Advances in microsurgical techniques, transplant immunology and the development of potent immunosuppressive agents have enabled the realization of such types of transplants. Over the past decade, a rapidly growing number of face and upper extremity transplantations have been performed worldwide with highly encouraging outcomes. However, despite the fact that surgical, immunological and functional results are highly encouraging, the need for long-term and high-dose immunosuppression to enable graft survival and to treat/reverse acute skin rejection episodes remains a pace-limiting obstacle towards wide spread application. In this chapter we review the history and development of this novel field, the functional and immunological outcomes based on the world experience, unique biological features of such transplants, mechanisms and treatment protocols for acute skin rejection, as well as novel concepts for immune modulation and tolerance induction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Swearingen B, Ravindra K, Xu H, Wu S, Breidenbach WC, Ildstad ST (2008) Science of composite tissue allotransplantation. Transplantation 86(5):627–635
Schneeberger S, Landin L, Jableki J, Butler P, Hoehnke C, Brandacher G, ESOT CTA Working Group (2011) Achievements and challenges in composite tissue allotransplantation. Transpl Int 24:760–769
Black KS, Hewitt CW, Fraser LA, Osborne JG, Achauer BM, Martin DC (1982) Cosmas and Damian in the laboratory. N Engl J Med 306:368–369
Gilbert R (1964) Transplant is successful with a cadaver forearm. Med Trib Med News 5:20–22
Benhaim P, Anthony JP, Lin LY, McCalmont TH, Mathes SJ (1993) A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443. Transplantation 56:911–917
Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ (1991) Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 87:401–411
Dubernard JM, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H (1999) Human hand allograft: report on first 6 months. Lancet 353:1315–1320
Foroohar A, Elliott RM, Kim TW, Breidenbach W, Shaked A, Levin LS (2011) The history and evolution of hand transplantation. Hand Clin 27:405–409
Ninkovic M, Weissenbacher A, Gabl M, Pierer G, Pratschke J, Margreiter R (2011) Functional outcome after hand and forearm transplantation: what can be achieved? Hand Clin 27:455–465
Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R (2010) The international registry on hand and composite tissue transplantation. Transplantation 90:1590–1594
Schneeberger S, Ninkovic M, Gabl M, Ninkovic M, Hussl H, Rieger M (2007) First forearm transplantation: outcome at 3 years. Am J Transplant 7:1753–1762
Ravindra KV, Buell JF, Kaufman CL, Blair B, Marvin M, Nagubandi R (2008) Hand transplantation in the United States: experience with 3 patients. Surgery 144:638–643
Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP (2005) Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction—long-term results. Am J Transplant 5:2539–2548
Kanitakis J, Jullien D, Petruzzo P, Hakim N, Claudy A, Revillard JP (2003) Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 76:688–693
Balk AHMM, Weimar W (1992) Chronic heart graft rejection in the clinical setting. In: Paul LC, Lolez K (eds) Organ transplantation: long-term results. Marcel Dekker, New York, pp 187–195
Wahlers T, Haverich A, Schäfers HJ, Hirt SW, Fieguth HG, Jurmann M (1993) Chronic rejection following lung transplantation. Incidence, time pattern and consequences. Eur J Cardiothorac Surg 7:319–323
Kaufman CL, Ouseph R, Blair B, Kutz JE, Tsai TM, Scheker LR (2012) Graft vasculopathy in clinical hand transplantation. Am J Transplant 12:1004–1016
Sarris GE, Smith JA, Shumway NE, Stinson EB, Oyer PE, Robbins RC (1994) Long-term results of combined heart-lung transplantation: the Stanford experience. J Heart Lung Transplant 13:940–949
Murase N, Demetris AJ, Matsuzaki T, Yagihashi A, Todo S, Fung J (1991) Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery 110:87–98
Schneeberger S, Gorantla VS, van Riet RP, Lanzetta M, Vereecken P, van Holder C (2008) Atypical acute rejection after hand transplantation. Am J Transplant 8:688–696
Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, Landin L (2008) The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 8:1396–1400
Hautz T, Zelger B, Grahammer J, Krapf C, Amberger A, Brandacher G (2010) Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 10:1200–1209
Gorantla VS, Demetris AJ (2011) Acute and chronic rejection in upper extremity transplantation: what have we learned? Hand Clin 27:481–493
Landin L, Cavadas PC, Ibañez J, Roger I, Vera-Sempere F (2009) CD3 + -mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 87:776–781
Kanitakis J, McGregor B, Badet L, Petruzzo P, Morelon E, Devauchelle B (2007) Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 84:265–267
Wu S, Xu H, Chen B, Wen Y, Ikusika OM, Ocker A (2011) Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation 92:627–633
Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Efalizumab Study Group (2003) A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 349:2004–2013
Brandacher G, Gorantla VS, Lee WP (2010) Hand allotransplantation. Semin Plast Surg 24:11–17
Ramsamooj R, Hewitt CW (2008) In: CW Hewitt et al. (eds), Transplantation of Composite Tissue Allografts. Springer, p 272–277
Schneeberger S, Lucchina S, Lanzetta M, Brandacher G, Bösmüller C, Steurer W (2005) Cytomegalovirus-related complications in human hand transplantation. Transplantation 80:441–447
Gordon CR, Abouhassan W, Avery RK (2011) What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation? Transplant Proc 43:3516–3520
Bonatti H, Brandacher G, Margreiter R, Schneeberger S (2009) Infectious complications in three double hand recipients: experience from a single center. Transplant Proc 41:517–520
Kobayashi H, Kobayashi M, McCauley RL, Herndon DN, Pollard RB, Suzuki F (1999) Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury. Clin Immunol 92:181–187
Gordon CR, Zor F, Siemionow M (2011) Skin area quantification in preparation for concomitant upper extremity and face transplantation: a cadaver study and literature review. Transplantation 91:1050–1056
Starzl TE, Zinkernagel RM (2001) Transplantation tolerance from a historical perspective. Nat Rev Immunol 1:233–239
Gorantla VS, Brandacher G, Schneeberger S, Zheng XX, Donnenberg AD, Losee JE, Lee WP (2011) Favoring the risk-benefit balance for upper extremity transplantation—the Pittsburgh Protocol. Hand Clin 27(4):511–520
Starzl TE (2007) Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 38(1–3):6–41
Hettiaratchy S, Melendy E, Randolph MA, Coburn RC, Neville DM Jr, Sachs DH, Huang CA, Lee WP (2004) Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 77(4):514–521
Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R (2011) Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation 92(12):1301–1308
Brandacher G, Gorantla VS, Schneeberger S, Shores JT, Imbriglia J, Azari K, Fletcher D, Zeevi A, Demetris A, Starzl TE, Losee JE, Lee WPA (2011) Hand/forearm transplantation using a novel cell-based immunomodulatory protocol—experience with five patients. Am J Transplant 11:190
Li XC, Turka LA (2010) An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 6(10):577–583
Matta BM, Castellaneta A, Thomson AW (2010) Tolerogenic plasmacytoid DC. Eur J Immunol 40(10):2667–2676
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Brandacher, G. (2013). Composite Tissue Transplantation. In: Zachary, A., Leffell, M. (eds) Transplantation Immunology. Methods in Molecular Biology, vol 1034. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-493-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-493-7_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-492-0
Online ISBN: 978-1-62703-493-7
eBook Packages: Springer Protocols